164 related articles for article (PubMed ID: 38330850)
1. Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy.
Adhikari A; Chauhan K; Adhikari M; Tiwari AK
Bioorg Med Chem; 2024 Feb; 100():117628. PubMed ID: 38330850
[TBL] [Abstract][Full Text] [Related]
2. Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders.
Tarale P; Alam MM
Inflammopharmacology; 2022 Jun; 30(3):821-842. PubMed ID: 35290551
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.
Han J; Chitu V; Stanley ER; Wszolek ZK; Karrenbauer VD; Harris RA
Cell Mol Life Sci; 2022 Apr; 79(4):219. PubMed ID: 35366105
[TBL] [Abstract][Full Text] [Related]
4. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
Rodriguez-Vieitez E; Kumar A; Malarte ML; Ioannou K; Rocha FM; Chiotis K
Methods Mol Biol; 2024; 2785():195-218. PubMed ID: 38427196
[TBL] [Abstract][Full Text] [Related]
5. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
Rodriguez-Vieitez E; Nordberg A
Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
[TBL] [Abstract][Full Text] [Related]
6. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).
Horti AG; Naik R; Foss CA; Minn I; Misheneva V; Du Y; Wang Y; Mathews WB; Wu Y; Hall A; LaCourse C; Ahn HH; Nam H; Lesniak WG; Valentine H; Pletnikova O; Troncoso JC; Smith MD; Calabresi PA; Savonenko AV; Dannals RF; Pletnikov MV; Pomper MG
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1686-1691. PubMed ID: 30635412
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
Jorge L; Martins R; Canário N; Xavier C; Abrunhosa A; Santana I; Castelo-Branco M
J Alzheimers Dis; 2021; 80(1):113-132. PubMed ID: 33523050
[TBL] [Abstract][Full Text] [Related]
8. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.
Janssen B; Mach RH
Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170
[TBL] [Abstract][Full Text] [Related]
9. Short-Term Colony-Stimulating Factor 1 Receptor Inhibition-Induced Repopulation After Stroke Assessed by Longitudinal
Barca C; Kiliaan AJ; Wachsmuth L; Foray C; Hermann S; Faber C; Schäfers M; Wiesmann M; Zinnhardt B; Jacobs AH
J Nucl Med; 2022 Sep; 63(9):1408-1414. PubMed ID: 35115368
[TBL] [Abstract][Full Text] [Related]
10. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
[TBL] [Abstract][Full Text] [Related]
11. Targeting the CSF-1/CSF-1R Axis: Exploring the Potential of CSF1R Inhibitors in Neurodegenerative Diseases.
Baek J; Jun J; Kim H; Bae H; Park H; Cho H; Han S; Shin HC; Hah JM
J Med Chem; 2024 Apr; 67(7):5699-5720. PubMed ID: 38530425
[TBL] [Abstract][Full Text] [Related]
12. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
13. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of Neuroinflammation in Alzheimer's Disease.
Zhou R; Ji B; Kong Y; Qin L; Ren W; Guan Y; Ni R
Front Immunol; 2021; 12():739130. PubMed ID: 34603323
[TBL] [Abstract][Full Text] [Related]
15. Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease.
Zhang M; Qian XH; Hu J; Zhang Y; Lin X; Hai W; Shi K; Jiang X; Li Y; Tang HD; Li B
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):455-467. PubMed ID: 37801139
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng F; Edison P
Nat Rev Neurol; 2021 Mar; 17(3):157-172. PubMed ID: 33318676
[TBL] [Abstract][Full Text] [Related]
17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
18. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
Cerami C; Iaccarino L; Perani D
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475165
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
